Skip to main content

A skin cream that can reduce body size.  Are historians sure that wasn’t what Ponce de Leon was seeking?  It’s certainly what buyers are looking for, if ads are any indication.  But claims like that have to be backed up by solid science, as is clear from the FTC’s $900,000 settlement with Beiersdorf, Inc., marketer of Nivea My Silhouette!  (Yes, the exclamation point is on the package.)

Ads for the product touted its “Bio-slim Complex,” a combination of ingredients that includes white tea and anise.  In one TV ad, as the voice-over claimed “New Nivea My Silhouette! with Bio-Slim Complex helps redefine the appearance of your silhouette and noticeably firms skin in just four weeks,” the ad showed a woman digging into the recesses of her closet, taking out an old pair of jeans, and trying them on to learn that they fit.  “So you can rediscover your favorite jeans and how they still get his attention.”

Um, OK.  Except that according to the FTC, using the product doesn’t really result in a significant reduction in body size.  That’s why the agency challenged the claim as false.

For pleadings watchers, there’s another interesting angle involving sponsored search engine keywords.  The FTC’s complaint mentions that the company had a deal with a leading search engine so that a webpage marketing Nivea My Silhouette! would show up in response to searches for information relating to body size.  Thus, if someone typed in a phrase like “stomach fat,” the search yielded a sponsored link at the top of the page that said “Want a toned stomach?  NIVEA My Silhouette Can Redefine the Appearance of Your Curves!” (The complaint offers no explanation for the wandering exclamation point.)

In addition to $900,000 in redress, the proposed order imposes tough injunctive provisions.  Under Part I, Beiersdorf can’t represent that any topically applied product causes substantial weight or fat loss or a substantial reduction in body size.

Subject to that provision, Part II says that Beiersdorf can’t represent that any “covered product” or “essentially equivalent product” — terms defined in the order — causes weight or fat loss or a reduction in body size, unless the claim is non-misleading and the company has competent and reliable scientific evidence substantiating the claim.  For claims covered by Part II, “competent and reliable scientific evidence” means at least two adequate and well-controlled human clinical studies of the covered product or of an essentially equivalent product “conducted by different researchers, independently of each other, that conform to acceptable designs and protocols and whose results, when considered in light of the entire body of relevant and reliable scientific evidence, are sufficient to substantiate that the representation is true.”  That provision also establishes that Beiersdorf will have the burden of proving that a product satisfies the definition of “essentially equivalent product.”

Under Part III, if Beiersdorf wants to make any other claims about the health benefits of a covered product, the company will need competent and reliable scientific evidence, defined for those representations as “tests, analyses, research, or studies that have been conducted and evaluated in an objective manner by qualified persons, and that are generally accepted in the profession to yield accurate and reliable results.”  That provision specifies that the evidence has to be “sufficient in quality and quantity based on standards generally accepted in the relevant scientific fields, when considered in light of the entire body of relevant and reliable scientific evidence, to substantiate that the representation is true.”


It is your choice whether to submit a comment. If you do, you must create a user name, or we will not post your comment. The Federal Trade Commission Act authorizes this information collection for purposes of managing online comments. Comments and user names are part of the Federal Trade Commission’s (FTC) public records system, and user names also are part of the FTC’s computer user records system. We may routinely use these records as described in the FTC’s Privacy Act system notices. For more information on how the FTC handles information that we collect, please read our privacy policy.

The purpose of this blog and its comments section is to inform readers about Federal Trade Commission activity, and share information to help them avoid, report, and recover from fraud, scams, and bad business practices. Your thoughts, ideas, and concerns are welcome, and we encourage comments. But keep in mind, this is a moderated blog. We review all comments before they are posted, and we won’t post comments that don’t comply with our commenting policy. We expect commenters to treat each other and the blog writers with respect.

  • We won’t post off-topic comments, repeated identical comments, or comments that include sales pitches or promotions.
  • We won’t post comments that include vulgar messages, personal attacks by name, or offensive terms that target specific people or groups.
  • We won’t post threats, defamatory statements, or suggestions or encouragement of illegal activity.
  • We won’t post comments that include personal information, like Social Security numbers, account numbers, home addresses, and email addresses. To file a detailed report about a scam, go to

We don't edit comments to remove objectionable content, so please ensure that your comment contains none of the above. The comments posted on this blog become part of the public domain. To protect your privacy and the privacy of other people, please do not include personal information. Opinions in comments that appear in this blog belong to the individuals who expressed them. They do not belong to or represent views of the Federal Trade Commission.

More from the Business Blog

Get Business Blog updates